Literature DB >> 1746468

Radiofrequency catheter ablation of accessory pathways: a learning experience.

R A Leather1, J W Leitch, G J Klein, G M Guiraudon, R Yee, Y H Kim.   

Abstract

Success rates of approximately 90% have recently been reported with radiofrequency catheter ablation of accessory pathways. This study determined whether this success could be repeated using a conservative approach generally limiting fluoroscopy time to 1 hour. Consecutive patients referred for management of arrhythmias associated with accessory atrioventricular pathways were included over a 9-month period. Ablation was attempted in 75 patients with 84 pathways. Overall success rate (including second attempts in 9 patients) was 60 of 84 accessory pathways (71%). Success rates for the first 3 months (n = 23) were 52%, the second 3 months (n = 23) 60% and the last 3 months (n = 38) 90%. Success rate varied with pathway location, with left lateral pathways having the best early success rates. Mean fluoroscopy time for successful procedures of 33 +/- 21 minutes was shorter than the time for unsuccessful procedures of 63 +/- 24 minutes (p = 0.001). There were no major complications and no patients with successful procedures (n = 53) have had recurrence of accessory pathway conduction or reciprocating tachycardia (follow-up 1 to 10 months). A conservative approach can yield success rates approaching 90% in a short time. The absence of major complications supports earlier reports suggesting that radiofrequency catheter ablation of accessory pathways is a reasonable first-line therapy in the Wolff-Parkinson-White syndrome.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1746468     DOI: 10.1016/0002-9149(91)90324-e

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  5 in total

Review 1.  Clinical competence in electrophysiological techniques.

Authors:  R W Campbell; R Charles; J C Cowan; C Garratt; J M McComb; J Morgan; E Rowland; R Sutton
Journal:  Heart       Date:  1997-10       Impact factor: 5.994

2.  Radiofrequency ablation of accessory atrioventricular pathways: predictive value of local electrogram characteristics for the identification of successful target sites.

Authors:  Y Bashir; S C Heald; D Katritsis; M Hammouda; A J Camm; D E Ward
Journal:  Br Heart J       Date:  1993-04

3.  Radiofrequency catheter ablation in patients with Wolff-Parkinson-White syndrome.

Authors:  R K Thakur; G J Klein; R Yee
Journal:  CMAJ       Date:  1994-09-15       Impact factor: 8.262

4.  Results of a comparative study of low energy direct current with radiofrequency ablation in patients with the Wolff-Parkinson-White syndrome.

Authors:  R Lemery; M Talajic; D Roy; L Lavoie; B Coutu; J T Hii; D Radzik; E Lavallee; R Cartier
Journal:  Br Heart J       Date:  1993-12

5.  Alfentanil-midazolam anaesthesia has no electrophysiological effects upon the normal conduction system or accessory pathways in patients with Wolff-Parkinson-White syndrome.

Authors:  M D Sharpe; W B Dobkowski; J M Murkin; G Klein; G Guiraudon; R Yee
Journal:  Can J Anaesth       Date:  1992-10       Impact factor: 5.063

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.